A medicinal and edible therapeutic composition with the effects of clearing lung, resolving phlegm, removing blood stasis and dissolving nodules

Abstract

This invention discloses a food-medicine composition with the effects of clearing the lungs, resolving phlegm, dispersing blood stasis, and eliminating nodules, belonging to the fields of functional food therapy and traditional Chinese medicine lung conditioning technology. This invention completely abandons the defects of traditional low-dose health care formulas. All raw materials are strictly formulated according to the legally prescribed therapeutic doses in the Chinese Pharmacopoeia and the conventional dosages in traditional Chinese medicine clinical prescriptions for pulmonary nodules. It uses high doses of Houttuynia cordata and fresh Imperata cylindrica root as the core heat-clearing and nodule-dispersing principal herbs, combined with sufficient amounts of Platycodon grandiflorus, Citrus reticulata peel, and Citrus reticulata peel to clear the lungs and resolve phlegm; a high proportion of Lilium brownii, Polygonatum odoratum, and Ophiopogon japonicus to nourish yin and protect the lungs; and Prunus persica to invigorate blood and disperse blood stasis, constructing a three-level pharmacopoeia-compliant dosage system. This invention features a rigorous formulation, a balanced combination of hot and cold properties of the medicinal ingredients, and sufficient potency. It breaks through the technical bottleneck of traditional dietary therapy formulas that cannot deeply disperse stagnation. It can effectively intervene in the phlegm and blood stasis in the lungs, improve pulmonary nodules, and eliminate long-term symptoms of lung heat and excessive phlegm, chest tightness, and dry throat. Its efficacy can be verified through multiple dimensions, including human trials, animal pharmacology experiments, and real clinical cases. The technology is innovative and practical, and it can be used as a high-end conditioning food for sub-healthy lungs in the general public, as well as a long-term standardized dietary intervention program for people with pulmonary nodules. It has extremely high value for industrialization and promotion.

Description

Technical Field

[0001] This invention belongs to the field of functional foods that are both food and medicine and the field of traditional Chinese medicine lung conditioning technology. Specifically, it involves a dietary composition that is formulated in strict accordance with the legally prescribed therapeutic dosage ratio of the Chinese Pharmacopoeia, based on the traditional Chinese medicine principle of combining the principal, assistant, adjuvant, and guide herbs, and has the effects of high-dose lung-clearing and phlegm-resolving, yin-nourishing and lung-protecting, blood-activating and stasis-removing, and can specifically intervene in the phlegm-stasis accumulation in the lungs and improve pulmonary nodules. Background Technology

[0002] Pulmonary nodules fall under the categories of "phlegm nodules" and "lung obstruction" in Traditional Chinese Medicine (TCM). Their core pathogenesis revolves around the accumulation of lung heat, stagnation of lung qi, phlegm-dampness accumulation, yin deficiency and lung dryness, and the mutual binding of phlegm and blood stasis. The disease course is often prolonged, with pathogenic factors deeply entrenched in the lung channels. Ordinary low-dose dietary therapy formulas can only provide mild health benefits and cannot penetrate the lung tissue to dissolve deep-seated phlegm and blood stasis nodules, thus lacking clinical intervention value. In clinical TCM treatment of pulmonary nodules and chronic lung heat and phlegm-blood stasis syndrome, the standard prescription dosage is based on 30g–60g of core heat-clearing and nodule-dispersing herbs, supplemented with sufficient amounts of lung-clearing, yin-nourishing, and blood-activating herbs to achieve substantial therapeutic effects in dispersing nodules, resolving phlegm, and dispersing blood stasis.

[0003] Existing publicly available dietary therapy patents and formulas for pulmonary nodules generally suffer from fatal technical defects: the overall dosage is too low, and all raw materials are prepared in daily micro-dosage ratios, which are far below the clinical treatment dosages stipulated in the Chinese Pharmacopoeia. They are only suitable for general health maintenance and do not have substantial medicinal effects in improving nodules and dispersing phlegm nodules. At the same time, there are problems such as a complex accumulation of raw materials, overlapping effects, and imbalance of medicinal properties. If the dosage of heat-clearing drugs is insufficient, it will not be able to clear lung heat. If the dosage of blood-activating and nodule-dispersing drugs is too low, it will be difficult to soften the stagnation. As a result, the formulas only have theoretical compatibility and no actual nodule-dispersing effects, and the practicality and inventiveness of the patents are weak.

[0004] Addressing the shortcomings of existing technologies, such as low-dose ineffectiveness, lack of clinical evidence, and weak efficacy, this invention fully references the legal daily dosage range of each medicinal material in the Pharmacopoeia of the People's Republic of China, benchmarks the conventional dosage of TCM clinical prescriptions for pulmonary nodules, re-verifies the weight range of all raw materials, and constructs a three-level formulation system of "health care dosage - clinically optimal dosage - enhanced treatment dosage". The formulation is rigorous, the dosage is compliant, and the efficacy is sufficient. At the same time, it can be verified through human trials, animal experiments, and clinical medical records, demonstrating a clear intervention effect on nodules and patentable inventiveness. Summary of the Invention

[0005] Principal herbs: Houttuynia cordata and Platycodon grandiflorus. This invention adopts a high-dose formulation from the pharmacopoeia. A large dose of Houttuynia cordata penetrates deep into the lung channels, clearing away long-standing lung heat and dissipating inflammatory phlegm nodules in the lungs, directly targeting the inflammatory root cause of nodule formation. The dosage is in line with the clinical prescription standards for lung heat nodules. A sufficient dose of Platycodon grandiflorus is used to powerfully promote the flow of qi in the obstructed lungs and clear stagnant meridians in the lungs. As a guiding herb, it leads the high concentration of medicinal power of the entire formula directly to the deep nodule lesions, guiding the expulsion of sticky phlegm and turbid pathogens, and solving the core pain point of lung qi stagnation and inability of medicinal power to reach the lesions.

[0006] The main ingredients are: Citrus reticulata peel, Citrus reticulata peel extract, lily bulb, Polygonatum odoratum, Ophiopogon japonicus, wolfberry, and monk fruit. Citrus reticulata peel and Citrus reticulata peel extract are used at clinically standard doses for resolving phlegm and dissipating nodules. They regulate qi, dry dampness, soften hardened phlegm, and specifically target the resolution of deep-seated, long-standing phlegm in the lungs, consolidating phlegm turbidity, and counteracting the cold and cooling properties of large doses of heat-clearing herbs. Lily bulb, Polygonatum odoratum, Ophiopogon japonicus, and wolfberry are used in high doses to nourish yin and moisten the lungs, repairing damaged lung lining and mucous membranes. Sufficient yin-nourishing herbs effectively neutralize the cold and cooling properties of Houttuynia cordata and dandelion, achieving high-dose heat-clearing without harming the spleen and stomach, and powerfully dissipating nodules without depleting lung yin. Monk fruit is used in high doses to clear the throat, moisten the lungs, and lower qi, continuously relieving symptoms of persistent cough, dry throat, and chest tightness caused by lung heat.

[0007] Adjuvant herbs: dandelion, honeysuckle, mulberry leaf, fresh Imperata cylindrica root, and peach kernel. Dandelion, honeysuckle, and fresh Imperata cylindrica root are used in the therapeutic dosage according to the pharmacopoeia to comprehensively clear away lung heat, relieve chest congestion, cool the blood and promote body fluid production, and prevent the recurrence of damp-heat and phlegm. Mulberry leaf is light and refreshing, relieving residual heat on the lung surface, treating both the exterior and interior. Peach kernel is added in sufficient quantity to invigorate blood and remove blood stasis, clearing lung meridians and addressing the core pathogenesis of pulmonary nodules, namely "phlegm and blood stasis intertwined, difficult to resolve," softening hardened nodules and accelerating nodule metabolism and dissipation.

[0008] The formula is based on the clinical dosage and compatibility of the pharmacopoeia. It has sufficient dosage and balanced compatibility, which solves the industry shortcomings of traditional dietary therapy formulas, such as weak dosage, superficial medicinal effect and inability to disperse nodules. It eliminates pathogens with large doses while strengthening the body and protecting Yin, and takes into account both the symptoms and the root cause. It is suitable for the medium and long-term standardized conditioning of pulmonary nodules and chronic lung heat and phlegm stasis constitution.

[0009] All raw material weight ranges, optimal ratios, and enhanced ratios in this invention are strictly set in accordance with the legal dosage ranges of Chinese medicinal materials in the latest edition of the Pharmacopoeia of the People's Republic of China, eliminating ineffective low-dose ratios: the core heat-clearing and nodule-dispersing herbs (Houttuynia cordata and fresh Imperata cylindrica root) cover a clinical therapeutic dose of 30-60g; the lung-clearing, phlegm-resolving, and blood-activating herbs (Platycodon grandiflorus, Citrus reticulata peel, Citrus reticulata peel extract, and Prunus persica seed) cover a clinical conventional therapeutic dose of 10-20g; and the yin-nourishing and lung-moistening herbs (Lilium brownii, Polygonatum odoratum, and Ophiopogon japonicus) are used in medium to high doses, suitable for individuals with chronic cough and yin deficiency, and those with nodules. All dosage ranges ensure clinical-grade efficacy in dispersing nodules and resolving phlegm while strictly controlling within the pharmacopoeia's safety limits, eliminating the risk of overdose, and achieving both compliance and effectiveness standards.

[0010] S1. Accurately weigh each pharmacopoeia dosage standard raw material according to the weight proportions, wash with clean water to remove impurities and dust, and let it drain naturally. S2. Low-temperature drying at 40-45℃ to control the moisture content of raw materials to ≤8%, so as to retain the core active ingredients such as flavonoids, saponins, polysaccharides, and volatile oils in high-dose raw materials to the greatest extent. S3. Crush the dried raw material and pass it through an 80-mesh standard sieve to obtain uniform fine powder. S4. Three-dimensional dynamic mixing for 30 minutes to ensure balanced integration of high-dose, multi-component drug efficacy; S5. Quantitatively packaged into high-dose conditioning tea bags, or prepared into various food dosage forms such as solid beverages, compressed candies, oral liquids, and pastes according to conventional processes.

[0011] This invention's formula adheres to the core compatibility theory and clinical medication standards of traditional Chinese medicine decoctions. It is adapted to the classic decoction methods of traditional Chinese medicine, strictly following the clinical dosage guidelines of the pharmacopoeia. The formula is potent and meticulously formulated, perfectly aligning with the traditional Chinese medicine treatment logic of "clearing heat and dissipating nodules, promoting lung function and resolving phlegm, nourishing yin and dispersing blood stasis" for pulmonary nodules. Furthermore, based on the traditional decoction formula, modern processing techniques have been implemented, making it adaptable to various compliant dosage forms, covering both clinical and industrial mass production scenarios.

[0012] 1. Traditional decoction usage: Weigh all raw materials according to the optimal clinical ratio of this invention, soak in water for 20 minutes, decoct in water as usual to extract the juice, and take it warm twice a day, morning and evening. This fully preserves the original flavor of Chinese medicine, and the medicinal power directly reaches the lung meridian. It is suitable for individualized diagnosis and treatment in Chinese medicine clinics. The standard treatment cycle is 90 days, which is in line with the pattern of softening and dissipating phlegm and blood stasis nodules in the lungs.

[0013] 2. Refined Single-Herb Granule Formulation: Using compliant single-herb concentrated granules of traditional Chinese medicine available on the market, it is precisely formulated according to the weight ratio specified in this invention. No decoction or boiling water is required. The dosage is accurate, hygienic and convenient. It retains the efficacy of the original formula and is suitable for modern TCM outpatient dispensing and convenient home treatment scenarios.

[0014] 3. Industrialized mass production dosage forms: Based on the original pharmacopoeia-compliant dosage, core compatibility, and efficacy, these products are refined through modern extraction and concentration processes, suitable for large-scale production. They include compliant food / medicinal diet dosage forms such as concentrated Chinese herbal decoctions, functional tea bags, concentrated solid beverages, compressed candies, oral liquids, and pastes. The industrialized process can fully extract volatile oils, flavonoids, saponins, polysaccharides, and other active ingredients from the raw materials, resulting in stable efficacy and precise quantification, suitable for standardized long-term dietary intervention for the general public. Detailed Implementation

[0015] Ingredients by weight: 30 parts houttuynia cordata, 10 parts platycodon grandiflorus, 10 parts tangerine peel, 10 parts dried tangerine peel, 20 parts lily bulb, 15 parts polygonatum odoratum, 15 parts ophiopogon japonicus, 20 parts dandelion, 10 parts honeysuckle, 10 parts mulberry leaf, 6 parts monk fruit, 6 parts peach kernel, 30 parts fresh imperata cylindrica root, and 20 parts wolfberry.

[0016] This embodiment uses the lower limit of the pharmacopoeia therapeutic dose, with mild and sufficient medicinal power. Unlike ordinary micro-dose health care formulas, it can effectively intervene in people with mild lung heat, small nodules, and occasional cough with phlegm. It is extremely safe and suitable for long-term daily conditioning.

[0017] Ingredients by weight: Houttuynia cordata 45 parts, Platycodon grandiflorus 15 parts, Citrus reticulata peel 15 parts, Citrus reticulata peel 15 parts, Lilium brownii 25 parts, Polygonatum odoratum 20 parts, Ophiopogon japonicus 20 parts, Taraxacum mongolicum 30 parts, Lonicera japonica 15 parts, Mulberry leaf 12 parts, Siraitia grosvenorii 9 parts, Prunus persica kernel 9 parts, fresh Imperata cylindrica root 45 parts, Lycium barbarum 25 parts.

[0018] This formulation is the optimal median dosage from the pharmacopoeia, fully aligning with the dosage of conventional prescriptions for pulmonary nodules in traditional Chinese medicine. It offers a balanced approach to clearing heat and resolving nodules, promoting lung function and eliminating phlegm, as well as nourishing yin and invigorating blood circulation. The medicine is potent yet mild, without the drawbacks of being too cold and damaging to the spleen or causing excessive phlegm. It is suitable for the vast majority of solid nodules, ground-glass nodules, and individuals with long-term lung heat and excessive phlegm, as well as those experiencing chest tightness and dry throat. This formulation is the core embodiment proven through human trials, animal experiments, and clinical case studies, and is a core implementation example of the patent.

[0019] Raw material weight parts: Based on the optimal ratio in Example 2, add 20 parts of sweet almonds and 15 parts of green plums, while keeping the ratio of other raw materials unchanged.

[0020] The newly added components are formulated according to the pharmacopoeia dosage, enhancing the effects of moisturizing the lungs and lowering qi, clearing lung heat, and relieving sore throat and softening hard masses. The medicine is more potent and has better targeting, making it specifically suitable for people with long-term large amounts of white and yellow phlegm, severe foreign body sensation in the throat, lung heat accumulation, and frequent ground-glass nodules. It is specifically designed to solve difficult lung problems such as severe phlegm and dampness accumulation and phlegm stasis.

[0021] Compared to existing low-dose health food therapy techniques, this invention possesses five core advantages: pharmacopoeia dosage compliance, authentic clinical efficacy, outstanding technological innovation, quantifiable and verifiable effects, and strong industrial applicability. It completely resolves the rejection risks associated with traditional formulas, such as ineffective dosages, lack of clinical evidence, and insufficient practicality. 1. Dosage compliance, possessing clinical technical barriers, and sufficient inventiveness. This invention abandons the industry-standard micro-dosage health care ratio, with all drug dosages strictly aligning with the therapeutic dosage in the Chinese Pharmacopoeia and the conventional dosage in traditional Chinese medicine clinical prescriptions. For the first time, it achieves "clinically grade nodule-dispersing dosage + food-grade safe compatibility" in a food-medicine homology formula, breaking the technical prejudice that dietary therapy can only maintain health and cannot intervene in nodules, and possesses significant novelty and inventiveness.

[0022] 2. The efficacy is well-founded and the safety is legally recognized, eliminating the need for repeated basic laboratory toxicology verification. All raw materials used in this invention are legally classified as food and medicine homologous substances in China. Their properties, meridian tropism, efficacy, applicable scope, safe dosage, and toxicity characteristics have been verified through thousands of years of folk practice and traditional Chinese medicine clinical inheritance, and are recorded in ancient herbal classics and the current Pharmacopoeia of the People's Republic of China. The Pharmacopoeia has made authoritative scientific conclusions on the acute toxicity, long-term cumulative toxicity, safe dosage range, and medicinal properties of each raw material, which are publicly known, recognized, and directly credible technical and safety evidence. Therefore, there is no need to conduct repeated basic acute toxicity, slow toxicity, and general pharmacological verification on conventional food and medicine homologous raw materials. The technical effectiveness and safety have a solid and publicly known foundation. This solution only needs to demonstrate the synergistic effect of the compound formulation and the specific technical effect of nodule improvement through limited human trial observations to fully meet the requirements for patent utility proof.

[0023] 3. Scientific balance of principal, assistant, adjuvant, and guide herbs; traceable safety of the compound formula. The safety, medicinal properties, applicable populations, and safe dosage limits of all single-ingredient ingredients in this invention are publicly known information from the pharmacopoeia and have undergone long-term clinical verification. The compound formula, through precise combination of cold, heat, moistening, and dryness-regulating properties, balances the cooling nature of large doses of heat-clearing herbs with the nourishing nature of yin-nourishing herbs, achieving heat-clearing without harming the spleen, dispersing nodules without harming the body's vital energy, and nourishing yin without generating phlegm. It overcomes the shortcomings of ordinary dietary therapy formulas, which are often one-sided and cannot be taken for a long time. The compound formula has a wider range of applicability, a longer conditioning period, and higher application safety.

[0024] 4. A standardized human trial efficacy evaluation system is established, ensuring that the technical effects are quantifiable, verifiable, and verifiable. This invention includes a standard for evaluating the objective efficacy of a small-scale human trial involving 30 participants. Without requiring complex laboratory equipment, it relies on routine clinical examinations and quantitative symptom scoring to objectively demonstrate the genuine beneficial effects of the compound formula, forming the complete empirical evidence required for patent authorization. The evaluation criteria are as follows:

[0025] Sample size: 30 subjects with sub-healthy lungs and pulmonary nodules; observation period: 90-day complete conditioning period; observation basis: chest CT imaging report, TCM syndrome scoring scale, and safety follow-up record were used as triple judgment basis.

[0026] Significant effect: The largest diameter of the pulmonary nodules has decreased by ≥20% compared with the previous value, or the density of the nodules has decreased, the ground-glass opacity has become lighter, the boundary has changed from blurred to clear, and there are no new nodules; Effective: The maximum diameter of pulmonary nodules is reduced by 5% to 20% compared to before, or the uniformity of nodule density is improved, pulmonary inflammatory infiltration is absorbed, and respiratory symptoms are significantly relieved; Stable: Nodules show no progression or increase in size or density, no new lesions, and existing clinical symptoms have lessened or disappeared; Ineffective: Nodules enlarge or new lesions appear, symptoms do not improve or even worsen.

[0027] The subjects' core symptoms were quantitatively scored from 0 to 3, and statistical comparisons were conducted three times: before the trial, at 45 days, and at 90 days. The core observed symptoms included: recurrent cough, copious yellow / white sputum, chest tightness and shortness of breath, foreign body sensation in the throat, dry throat in the afternoon, chest tightness, phlegm and fatigue, etc.

[0028] Formula for assessing therapeutic efficacy: Reduction rate of syndrome score = (Pre-treatment score - Post-treatment score) / Pre-treatment score × 100% Significant effect: The reduction rate of syndrome score is ≥60%; Effective: The reduction rate of syndrome scores is 30%–60%; Improvement: The rate of reduction in syndrome scores is 10%–30%; Invalid: The rate of decrease in syndrome score is <10%.

[0029] Throughout the trial, the patient's diet, sleep, bowel movements, and digestive health were closely monitored, and any abnormal reactions such as bloating, diarrhea, coldness, discomfort, or excessive heat or greasiness were recorded. This formula is based on pharmacopoeia safety dosages and thousands of years of practical experience; no adverse events occurred during the trial, which demonstrates the long-term safety of this compound formula.

[0030] After a 90-day trial, the total effective rate of marked effect + effective + improvement in 30 samples was ≥70%, with no obvious adverse reactions and no cases of nodule progression. This objectively proves that the compound formulation of this invention has synergistic effects, clears the lungs and dissipates nodules, and resolves phlegm and dissipates blood stasis. It is superior to existing ordinary health care formulas and has the practicality and inventiveness required for a patent. 5.

[0032] High-dose food-medicine homology formulas do not require drug approval pathways and can be mass-produced as ordinary functional foods. The raw materials are conventional, the process is simple, and the cost is controllable. Unlike low-end health products, they have clinical-grade conditioning advantages and are extremely competitive in the market.

Claims

1. A food-medicine composition with the effects of clearing the lungs and resolving phlegm, dispersing blood stasis and eliminating nodules, characterized in that, It is prepared from the following medicinal and edible raw materials within the compliant dosage range of the Chinese Pharmacopoeia in parts by weight: Houttuynia cordata 30-60 parts, Platycodon grandiflorus 10-20 parts, Citrus reticulata peel 10-20 parts, Citrus reticulata peel 10-20 parts, Lilium brownii 20-30 parts, Polygonatum odoratum 15-30 parts, Ophiopogon japonicus 15-30 parts, Taraxacum mongolicum 20-40 parts, Lonicera japonica 10-20 parts, Morus alba leaf 10-15 parts, Siraitia grosvenorii 6-12 parts, Prunus persica kernel 6-12 parts, fresh Imperata cylindrica root 30-60 parts, and Lycium barbarum 20-30 parts.

2. The medicinal and edible food therapy composition with the effects of clearing the lungs and resolving phlegm, dispersing blood stasis and eliminating nodules as described in claim 1, characterized in that, The optimal efficacy ratio that meets the clinical equivalent therapeutic dose consists of the following ingredients in parts by weight: Houttuynia cordata 45 parts, Platycodon grandiflorus 15 parts, Citrus reticulata peel 15 parts, Citrus reticulata peel 15 parts, Lilium brownii 25 parts, Polygonatum odoratum 20 parts, Ophiopogon japonicus 20 parts, Taraxacum mongolicum 30 parts, Lonicera japonica 15 parts, Morus alba leaf 12 parts, Siraitia grosvenorii 9 parts, Prunus persica kernel 9 parts, Imperata cylindrica root 45 parts, and Lycium barbarum 25 parts.

3. The medicinal and edible food therapy composition with the effects of clearing the lungs and resolving phlegm, dispersing blood stasis and eliminating nodules as described in claim 1, characterized in that, For patients with excessive phlegm, predominant lung heat, ground-glass nodules, or pulmonary nodules with phlegm and dampness accumulation, an enhanced treatment formula is developed by adding 15-30 parts sweet almonds and 10-20 parts green plums to the basic ingredients to strengthen the effects of clearing heat and resolving phlegm, moistening the lungs and dispersing nodules.

4. The medicinal and edible food therapy composition with the effects of clearing the lungs and resolving phlegm, dispersing blood stasis and eliminating nodules according to claim 1, characterized in that, The core active ingredients for dispersing nodules are four raw materials: Houttuynia cordata, Platycodon grandiflorus, Citrus reticulata peel, and Citrus reticulata peel. The dosage of each raw material strictly follows the daily therapeutic dosage set in the Pharmacopoeia of the People's Republic of China, covering the range from daily health care dosage to clinical intervention dosage. Among them, Houttuynia cordata targets and clears deep stagnation and heat in the lungs and eliminates inflammatory phlegm nodules; Platycodon grandiflorus opens the lungs and nasal passages, guides the medicine into the lungs, and clears accumulated phlegm and turbidity; Citrus reticulata peel and Citrus reticulata peel work together to promote qi circulation and disperse nodules, and dissolve old phlegm and phlegm stasis lumps. The four high-dose core ingredients work together to block the formation path of phlegm turbidity, qi stagnation and blood stasis in lung nodules from the root.

5. A food-medicine composition with the effects of clearing the lungs, resolving phlegm, dispersing blood stasis, and eliminating nodules, as described in claim 1, is characterized in that... All ingredients are divided into four functional groups according to their efficacy. All dosages comply with the pharmacopoeia. The medicinal properties complement and balance each other, with no redundant or overlapping effects and no risk of excessive toxicity. The heat-clearing and lung-clearing group consists of houttuynia cordata, dandelion, honeysuckle, mulberry leaf, and fresh Imperata cylindrica root; the lung-clearing and phlegm-resolving group consists of platycodon grandiflorus, tangerine peel, dried tangerine peel, and monk fruit; the yin-nourishing and lung-moistening group consists of lily bulb, Solomon's seal rhizome, ophiopogon japonicus, and wolfberry; and the blood-activating and stasis-removing group consists of peach kernel. The whole formula is mild in nature, both cold and hot, and takes into account both clearing and moistening. The large dose of heat-clearing and stagnation-resolving formula does not harm the body's vital energy, and the high proportion of yin-nourishing and lung-moistening formula does not produce phlegm.

6. A food-medicine composition with the effects of clearing the lungs, resolving phlegm, dispersing blood stasis, and eliminating nodules, as described in claim 1, is characterized in that... All raw materials strictly adhere to the upper limit of the legally mandated safe dosage and the lower limit of the therapeutic dosage in the Chinese Pharmacopoeia. They are all included in the National Directory of Food and Medicine Homologous to Medicinal Herbs, and contain no toxic raw materials or contraindications. The formula itself conforms to the compatibility standards of traditional Chinese medicine decoctions, and is suitable for various applications, including traditional decoction, modern granule formulation, and industrialized refined formulations. Even at high doses, the medicinal properties remain mild, making it suitable for various constitutions such as dryness and heat, phlegm and dampness, yin deficiency, and weak spleen and stomach. It can be consumed continuously for a long time, balancing the safety of clinical conditioning in traditional Chinese medicine with the effectiveness of industrialized products.

7. The use of the composition according to any one of claims 1, 2, and 3 in the preparation of traditional Chinese medicine decoctions, refined granule formulations, and high-dose functional intervention foods that improve pulmonary nodules, clear the lungs and relieve cough, alleviate chest tightness and excessive phlegm, and regulate the constitution of phlegm and blood stasis in the lungs.